Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

Sumra Nazir, Vera Jankowski, Guzide Bender, Stephen Zewinger, Kerry-Anne Rye, Emiel P. C. van der Vorst*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

20 Citations (Web of Science)

Abstract

High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially contributes to the reverse cholesterol transport pathway. Over recent years it has become clear that the effect of HDL on immune modulation is not only dependent on HDL concentration but also and perhaps even more so on HDL function. This review will provide a concise general introduction to HDL followed by an overview of post-translational modifications of HDL and a detailed overview of the role of HDL in inflammatory diseases. The clinical potential of HDL and its main apolipoprotein constituent, apoA-I, is also addressed in this context. Finally, some conclusions and remarks that are important for future HDL-based research and further development of HDL-focused therapies are discussed. (C) 2020 The Author(s). Published by Elsevier B.V.

Original languageEnglish
Pages (from-to)94-119
Number of pages26
JournalAdvanced Drug Delivery Reviews
Volume159
DOIs
Publication statusPublished - 2020

Keywords

  • High-density lipoproteins
  • Inflammation
  • Metabolic diseases
  • Infectious diseases
  • Auto-immune diseases
  • Neurological diseases
  • Chronic kidney disease
  • APOLIPOPROTEIN-A-I
  • SYSTEMIC-LUPUS-ERYTHEMATOSUS
  • ESTER TRANSFER PROTEIN
  • CHOLESTEROL EFFLUX CAPACITY
  • ATHEROGENIC LIPID PROFILE
  • TYPE-2 DIABETES-MELLITUS
  • CORONARY-ARTERY-DISEASE
  • EXTENDED-RELEASE NIACIN
  • ALTERS HDL COMPOSITION
  • ACUTE LUNG INJURY

Cite this